Skip to main content

Heron Therapeutics: Q4 Earnings Snapshot

CARY, N.C. (AP) — CARY, N.C. (AP) — Heron Therapeutics Inc. (HRTX) on Thursday reported a loss of $3 million in its fourth quarter.

On a per-share basis, the Cary, North Carolina-based company said it had a loss of 2 cents.

The pharmaceutical company posted revenue of $40.6 million in the period.

For the year, the company reported a loss of $20.2 million, or 12 cents per share. Revenue was reported as $154.9 million.

Heron Therapeutics expects full-year revenue in the range of $173 million to $183 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX

TEst Draft

updated by pwenzel 3:13pm
Read Next Story